A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib
Sign Up to like & getrecommendations! Published in 2022 at "Lung Cancer: Targets and Therapy"
DOI: 10.2147/lctt.s383662
Abstract: Abstract KRASG12C is one of the most common oncogenes in non-small cell lung cancer (NSCLC) and is associated with a poor prognosis. Historically, KRAS mutations have been difficult to target due to lack of binding… read more here.
Keywords: mutations nsclc; long overdue; targeted treatment; kras mutations ... See more keywords